Buscar
Mostrando ítems 11-20 de 1463
Immune dysfunction following COVID‐19, especially in severe patients
The coronavirus disease 2019 (COVID-19) has been spreading worldwide. Severe cases quickly
progressed with unfavorable outcomes.We aim to investigate the clinical features of COVID-19 and
identify the risk factors ...
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
(ERJ Open Res. 2022 Feb, 2022)
Due to the large number of patients with severe coronavirus disease 2019 (COVID-19), many were treated outside the traditional walls of the intensive care unit (ICU), and in many cases, by personnel who were not trained ...
Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19
Background: Despite the death rate of COVID-19 is less than 3%, the fatality rate of severe/critical cases is high,
according to World Health Organization (WHO). Thus, screening the severe/critical cases before symptom ...
Epidemiology of COVID-19 in Individuals under 18 Years Old in Cartagena, Colombia: An Ecological Study of the First 14 Months of the Pandemic
(MDPI, 2022)
The epidemiology of the coronavirus disease (COVID-19) has been scarcely described in individuals under 18 years old, particularly during the first months of the pandemic. The study aimed to describe the COVID-19 epidemiology ...
Etoposide-based therapy for severe forms of COVID-19
The new coronavirus infection COVID-19 has quickly become a global health emergency. Mortality is principally
due to severe Acute Respiratory Distress Syndrome (ARDS) which relays only on supportive treatment.
Numerous ...
Arginine depletion as a therapeutic approach for patients with COVID-19
The COVID-19 pandemic, caused by SARS-CoV-2, is a source of significant morbidity and
mortality worldwide, and effective treatments are urgently needed. Clinical trials have largely
focused on direct anti-viral therapies ...
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
Objectives: Coronavirus Disease 2019 (COVID-19) is a new respiratory and systemic disease which needs
quick identification of potential critical patients. This meta-analysis aimed to explore the relationship
between ...